世界のインフルエンザワクチン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Influenza Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP01115)・商品コード:QYR20AP01115
・発行会社(調査会社):QYResearch
・発行日:2020年3月23日(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、インフルエンザワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、インフルエンザワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(全ウイルスワクチン、スプリットウイルスワクチン、サブユニットワクチン、生弱毒化ウイルスワクチン)、用途別市場規模(子供向け(6か月-3歳)、大人向け・3年以上の子供向け)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・インフルエンザワクチンの種類別市場2015-2026:全ウイルスワクチン、スプリットウイルスワクチン、サブユニットワクチン、生弱毒化ウイルスワクチン
・インフルエンザワクチンの用途別市場2015-2026:子供向け(6か月-3歳)、大人向け・3年以上の子供向け
・インフルエンザワクチンの北米市場分析
・インフルエンザワクチンのアジア市場分析
・インフルエンザワクチンの中南米市場分析
・インフルエンザワクチンの中東・アフリカ市場分析
・関連企業情報:CSL、GSK、Sanofi Pasteur、Mylan、AstraZeneca、Pfizer、Johnson & Johnson
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines In 2018 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion In 2018 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% In 2018. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
In 2019, the global Influenza Vaccine market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Influenza Vaccine.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Influenza Vaccine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Influenza Vaccine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Influenza Vaccine market. Readers of the report can become informed about current and future trends of the global Influenza Vaccine market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Influenza Vaccine markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Influenza Vaccine market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Influenza Vaccine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Influenza Vaccine market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Influenza Vaccine market is segmented into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Market Segment by Application, the Influenza Vaccine market is segmented into
For Children (6 months to 3 years)
For Adults and Children over 3 years

This report includes the following manufacturers; we can also add the other companies as you want.
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

The study objectives are:
To analyze and research the global Influenza Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Influenza Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Influenza Vaccine are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Influenza Vaccine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Whole Virus Vaccines
1.3.3 Split Virus Vaccines
1.3.4 Subunit Vaccines
1.3.5 Live Attenuated Virus Vaccines
1.4 Market Segment by Application
1.4.1 Global Influenza Vaccine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 For Children (6 months to 3 years)
1.4.3 For Adults and Children over 3 years
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Influenza Vaccine Revenue (2015-2026)
2.1.1 Global Influenza Vaccine Revenue (2015-2026)
2.1.2 Global Influenza Vaccine Sales (2015-2026)
2.2 Influenza Vaccine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Influenza Vaccine Sales by Regions (2015-2020)
2.2.2 Global Influenza Vaccine Revenue by Regions (2015-2020)
2.3 Global Top Influenza Vaccine Regions (Countries) Ranking by Market Size
2.4 Influenza Vaccine Industry Trends
2.4.1 Influenza Vaccine Market Top Trends
2.4.2 Market Drivers
2.4.3 Influenza Vaccine Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Influenza Vaccine Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Influenza Vaccine Manufacturers by Sales (2015-2020)
3.1.1 Global Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Influenza Vaccine Sales in 2019
3.2 Global Top Manufacturers Influenza Vaccine by Revenue
3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2019)
3.4 Global Influenza Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Influenza Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Influenza Vaccine Market
3.7 Key Manufacturers Influenza Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Influenza Vaccine Historic Market Review by Type (2015-2020)
4.1.2 Global Influenza Vaccine Sales Market Share by Type (2015-2020)
4.1.3 Global Influenza Vaccine Revenue Market Share by Type (2015-2020)
4.1.4 Influenza Vaccine Price by Type (2015-2020)
4.1 Global Influenza Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.3 Global Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.4 Influenza Vaccine Price Forecast by Type (2021-2026)

5 Global Influenza Vaccine Market Size by Application
5.1 Global Influenza Vaccine Historic Market Review by Application (2015-2020)
5.1.2 Global Influenza Vaccine Sales Market Share by Application (2015-2020)
5.1.3 Global Influenza Vaccine Revenue Market Share by Application (2015-2020)
5.1.4 Influenza Vaccine Price by Application (2015-2020)
5.2 Global Influenza Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.3 Global Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.4 Influenza Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Influenza Vaccine Breakdown Data by Company
6.2 North America Influenza Vaccine Breakdown Data by Type
6.3 North America Influenza Vaccine Breakdown Data by Application
6.4 North America Influenza Vaccine Breakdown Data by Countries
6.4.1 North America Influenza Vaccine Sales by Countries
6.4.2 North America Influenza Vaccine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Influenza Vaccine Breakdown Data by Company
7.2 Europe Influenza Vaccine Breakdown Data by Type
7.3 Europe Influenza Vaccine Breakdown Data by Application
7.4 Europe Influenza Vaccine Breakdown Data by Countries
7.4.1 Europe Influenza Vaccine Sales by Countries
7.4.2 Europe Influenza Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Influenza Vaccine Breakdown Data by Company
8.2 Asia Pacific Influenza Vaccine Breakdown Data by Type
8.3 Asia Pacific Influenza Vaccine Breakdown Data by Application
8.4 Asia Pacific Influenza Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Influenza Vaccine Sales by Regions
8.4.2 Asia Pacific Influenza Vaccine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Influenza Vaccine Breakdown Data by Company
9.2 Latin America Influenza Vaccine Breakdown Data by Type
9.3 Latin America Influenza Vaccine Breakdown Data by Application
9.4 Latin America Influenza Vaccine Breakdown Data by Countries
9.4.1 Latin America Influenza Vaccine Sales by Countries
9.4.2 Latin America Influenza Vaccine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Influenza Vaccine Breakdown Data by Type
10.2 Middle East and Africa Influenza Vaccine Breakdown Data by Application
10.3 Middle East and Africa Influenza Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Influenza Vaccine Sales by Countries
10.3.2 Middle East and Africa Influenza Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Business Overview and Total Revenue (2019 VS 2018)
11.1.3 CSL Influenza Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 CSL Influenza Vaccine Products and Services
11.1.5 CSL SWOT Analysis
11.1.6 CSL Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.2.3 GSK Influenza Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 GSK Influenza Vaccine Products and Services
11.2.5 GSK SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Sanofi Pasteur Influenza Vaccine Products and Services
11.3.5 Sanofi Pasteur SWOT Analysis
11.3.6 Sanofi Pasteur Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Mylan Influenza Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Mylan Influenza Vaccine Products and Services
11.4.5 Mylan SWOT Analysis
11.4.6 Mylan Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 AstraZeneca Influenza Vaccine Products and Services
11.5.5 AstraZeneca SWOT Analysis
11.5.6 AstraZeneca Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Pfizer Influenza Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Pfizer Influenza Vaccine Products and Services
11.6.5 Pfizer SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Influenza Vaccine Products and Services
11.7.5 Johnson & Johnson SWOT Analysis
11.7.6 Johnson & Johnson Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Influenza Vaccine Sales Channels
12.2.2 Influenza Vaccine Distributors
12.3 Influenza Vaccine Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Influenza Vaccine Sales Forecast (2021-2026)
13.1.1 Global Influenza Vaccine Sales Forecast by Regions (2021-2026)
13.1.2 Global Influenza Vaccine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Influenza Vaccine Sales Forecast (2021-2026)
13.2.2 North America Influenza Vaccine Revenue Forecast (2021-2026)
13.2.3 North America Influenza Vaccine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Influenza Vaccine Sales Forecast (2021-2026)
13.3.2 Europe Influenza Vaccine Revenue Forecast (2021-2026)
13.3.3 Europe Influenza Vaccine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Influenza Vaccine Sales Forecast (2021-2026)
13.4.2 Asia Pacific Influenza Vaccine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Influenza Vaccine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Influenza Vaccine Sales Forecast (2021-2026)
13.5.2 Latin America Influenza Vaccine Revenue Forecast (2021-2026)
13.5.3 Latin America Influenza Vaccine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Influenza Vaccine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Influenza Vaccine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Influenza Vaccine Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Influenza Vaccine Key Market Segments
Table 2. Ranking of Global Top Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza Vaccine Market Size Growth Rate by Type 2021-2026 (K Doses) & (Million US$)
Table 4. Major Manufacturers of Whole Virus Vaccines
Table 5. Major Manufacturers of Split Virus Vaccines
Table 6. Major Manufacturers of Subunit Vaccines
Table 7. Major Manufacturers of Live Attenuated Virus Vaccines
Table 8. Global Influenza Vaccine Market Share by Application 2019-2025 (K Doses)
Table 9. Global Influenza Vaccine Market Size by Regions 2015-2020 (K Doses) & (Million US$)
Table 10. Global Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 11. Global Influenza Vaccine Sales Market Share by Regions 2015-2020
Table 12. Global Influenza Vaccine Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Influenza Vaccine Revenue Market Share by Regions 2015-2020
Table 14. Top Influenza Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Influenza Vaccine Key Drivers: Impact Analysis (2021-2026)
Table 17. Influenza Vaccine Key Challenges
Table 18. Main Points Interviewed from Key Influenza Vaccine Players: Views for Future
Table 19. Global Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 20. Global Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 21. Influenza Vaccine Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 23. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2019)
Table 25. Key Manufacturers Influenza Vaccine Average Selling Price (ASP) (2015-2020) (USD/Doses)
Table 26. Key Manufacturers Influenza Vaccine Plants/Factories Distribution
Table 27. Key Manufacturers Influenza Vaccine Area Served
Table 28. Date of Key Manufacturers Enter into Influenza Vaccine Market
Table 29. Key Manufacturers Influenza Vaccine Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Whole Virus Vaccines Sales and Revenue (2015-2020) (K Doses) & (Million US$)
Table 32. Global Split Virus Vaccines Sales and Revenue (2015-2020) (K Doses) & (Million US$)
Table 33. Global Subunit Vaccines Sales ana Revenue (2015-2020) (K Doses) & (Million US$)
Table 34. Global Live Attenuated Virus Vaccines Sales ana Revenue (2015-2020) (K Doses) & (Million US$)
Table 35. Global Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 36. Global Influenza Vaccine Sales Share by Type (2015-2020)
Table 37. Global Influenza Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Influenza Vaccine Price (K Doses) by Type (2015-2020)
Table 39. Global Influenza Vaccine Sales (K Doses) by Type (2021-2026)
Table 40. Global Influenza Vaccine Sales Share by Type (2021-2026)
Table 41. Global Influenza Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Influenza Vaccine Revenue Share by Type (2021-2026)
Table 43. Global Influenza Vaccine Price (K Doses) by Type (2021-2026)
Table 44. Global Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 45. Global Influenza Vaccine Sales Share by Application (2015-2020)
Table 46. Global Influenza Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Influenza Vaccine Price by Application 2015-2020 (USD/Doses)
Table 48. Global Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 49. Global Influenza Vaccine Sales Share by Application (2015-2020)
Table 50. Global Influenza Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Influenza Vaccine Revenue Share by Application (2021-2026)
Table 52. Global Influenza Vaccine Price (K Doses) by Application (2021-2026)
Table 53. North America Influenza Vaccine Sales by Company (2015-2020) (K Doses)
Table 54. North America Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 55. North America Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 56. North America Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 57. North America Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 58. North America Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 59. North America Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 60. North America Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 61. North America Influenza Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 63. Europe Influenza Vaccine Sales by Company (2015-2020) (K Doses)
Table 64. Europe Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 65. Europe Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 66. Europe Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 67. Europe Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 68. Europe Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 69. Europe Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 70. Europe Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 71. Europe Influenza Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Influenza Vaccine Sales by Regions (2015-2020) (K Doses)
Table 74. Asia Pacific Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 76. Asia Pacific Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 78. Asia Pacific Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 80. Asia Pacific Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Influenza Vaccine Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Influenza Vaccine Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Influenza Vaccine Sales by Company (2015-2020) (K Doses)
Table 84. Latin America Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 85. Latin America Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 86. Latin America Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 87. Latin America Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 88. Latin America Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 89. Latin America Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 90. Latin America Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 91. Latin America Influenza Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 94. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 96. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 98. Middle East and Africa Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Influenza Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 101. CSL Company Details
Table 102. CSL Description and Business Overview
Table 103. CSL Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 104. CSL Influenza Vaccine Sales Growth Rate (2015-2020)
Table 105. CSL Influenza Vaccine Sales Market Share in Global Market
Table 106. CSL Recent Development
Table 107. GSK Company Details
Table 108. GSK Description and Business Overview
Table 109. GSK Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 110. GSK Influenza Vaccine Sales Growth Rate (2015-2020)
Table 111. GSK Influenza Vaccine Sales Market Share in Global Market
Table 112. GSK Recent Development
Table 113. Sanofi Pasteur Company Details
Table 114. Sanofi Pasteur Description and Business Overview
Table 115. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 116. Sanofi Pasteur Influenza Vaccine Sales Growth Rate (2015-2020)
Table 117. Sanofi Pasteur Influenza Vaccine Sales Market Share in Global Market
Table 118. Sanofi Pasteur Recent Development
Table 119. Mylan Company Details
Table 120. Mylan Description and Business Overview
Table 121. Mylan Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 122. Mylan Influenza Vaccine Sales Growth Rate (2015-2020)
Table 123. Mylan Influenza Vaccine Sales Market Share in Global Market
Table 124. Mylan Recent Development
Table 125. AstraZeneca Company Details
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 128. AstraZeneca Influenza Vaccine Sales Growth Rate (2015-2020)
Table 129. AstraZeneca Influenza Vaccine Sales Market Share in Global Market
Table 130. AstraZeneca Recent Development
Table 131. Pfizer Company Details
Table 132. Pfizer Description and Business Overview
Table 133. Pfizer Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 134. Pfizer Influenza Vaccine Sales Growth Rate (2015-2020)
Table 135. Pfizer Influenza Vaccine Sales Market Share in Global Market
Table 136. Pfizer Recent Development
Table 137. Johnson & Johnson Company Details
Table 138. Johnson & Johnson Description and Business Overview
Table 139. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 140. Johnson & Johnson Influenza Vaccine Sales Growth Rate (2015-2020)
Table 141. Johnson & Johnson Influenza Vaccine Sales Market Share in Global Market
Table 142. Johnson & Johnson Recent Development
Table 143. Influenza Vaccine Distributors List
Table 144. Influenza Vaccine Customers List
Table 145. Global Influenza Vaccine Sales Forecast 2021-2026 (K Doses) & (Million US$)
Table 146. Global Influenza Vaccine Sales Forecast by Type 2021-2026 (K Doses)
Table 147. Global Influenza Vaccine Sales Forecast by Application 2021-2026 (K Doses)
Table 148. Global Influenza Vaccine Sales Forecast by Regions 2021-2026 (K Doses)
Table 149. Global Influenza Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 150. North America Influenza Vaccine Sales Forecast by Countries 2021-2026 (K Doses)
Table 151. North America Influenza Vaccine Revenue Forecast by Countries 2021-2026
Table 152. Europe Influenza Vaccine Sales Forecast by Countries 2021-2026 (K Doses)
Table 153. Europe Influenza Vaccine Revenue Market Share Forecast by Countries 2021-2026
Table 154. Asia Pacific Influenza Vaccine Sales Forecast by Regions 2021-2026 (K Doses)
Table 155. Asia Pacific Influenza Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 156. Latin America Influenza Vaccine Sales Forecast by Countries 2021-2026 (K Doses)
Table 157. Latin America Influenza Vaccine Revenue Forecast by Countries 2021-2026 (Million US$)
Table 158. Middle East and Africa Influenza Vaccine Sales Forecast by Regions 2021-2026 (K Doses)
Table 159. Middle East and Africa Influenza Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Sales Market Shar by Type 2015-2026
Figure 3. Whole Virus Vaccines Figures
Figure 4. Split Virus Vaccines Figures
Figure 5. Subunit Vaccines Figures
Figure 6. Live Attenuated Virus Vaccines Figures
Figure 7. Global Influenza Vaccine Sales Market Share by Application in 2019 & 2026
Figure 8. For Children (6 months to 3 years) Use Case
Figure 9. For Adults and Children over 3 years Use Case
Figure 10. Influenza Vaccine Report Years Considered
Figure 11. Global Influenza Vaccine Market Size 2015-2026 (Million US$)
Figure 12. Global Influenza Vaccine Sales 2015-2020 (K Doses)
Figure 13. Global Influenza Vaccine Market Size Market Share by Regions 2015-2020
Figure 14. Global Influenza Vaccine Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Influenza Vaccine Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Vaccine Sales in 2019
Figure 18. Influenza Vaccine Value Share by Manufacturers in 2019
Figure 19. Influenza Vaccine Revenue Share by Manufacturers In 2019
Figure 20. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Influenza Vaccine Revenue Share by Type (2015-2020)
Figure 22. Global Influenza Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Influenza Vaccine Revenue Share by Application (2015-2020)
Figure 25. Global Influenza Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Influenza Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 28. Canada Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 29. Europe Influenza Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 31. France Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 32. U.K. Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. Italy Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 34. Russia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Asia Pacific Influenza Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Japan Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 38. South Korea Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 39. India Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 40. Australia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 41. Taiwan Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 42. Indonesia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Thailand Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Malaysia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Philippines Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Vietnam Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. Latin America Influenza Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Brazil Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Argentina Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Middle East and Africa Influenza Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Saudi Arabia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 54. U.A.E Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 55. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Influenza Vaccine Value Chain
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. North America Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 66. North America Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Europe Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 68. Europe Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 69. Asia Pacific Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 70. Asia Pacific Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Latin America Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 72. Latin America Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Middle East and Africa Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 74. Middle East and Africa Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed


【掲載企業】

CSL、GSK、Sanofi Pasteur、Mylan、AstraZeneca、Pfizer、Johnson & Johnson

★調査レポート[世界のインフルエンザワクチン市場:成長動向・競争分析2020-2026] (コード:QYR20AP01115)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のインフルエンザワクチン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆